フーディン (First Edition Holofoil)
Alakazam
基本拡張パック
Base Expansion Pack · #116
Overview
Legality, special rules, and flavor text
Format legality
- StandardNot Legal
- UnlimitedLegal
- ExpandedNot Legal
- Gym Leader ChallengeNot Legal
Card details
Printing, type line, and catalog data
Identity & printing
- Card ID
- ecard1_ja-116--firstEditionHolofoil
- Name
- フーディン (First Edition Holofoil)
Alakazam - Number
- 116
- Printed number
- 116/128
- Rarity
- レアホロ
Rare Holo - Rarity code
- ★H
- Variant
- First Edition Holofoil
Type line & stats
- Supertype
- ポケモン
Pokémon - Subtypes
- 2進化
Stage 2 - Types
- 超
Psychic - HP
- 100
Set, artist & references
- Retreat cost
- 1
Colorless - Artist
- Hajime Kusajima
- Language
- Japanese
- Set name
- 基本拡張パック
Base Expansion Pack - Game name
- Pokémon Japan
Battle
Abilities, attacks, weakness & resistance
Abilities
- ポケパワー: Psymimic
Once during your turn, instead of Alakazam's normal attack, you may choose 1 of your opponent's Pokémon's attacks. Alakazam copies that attack including its Energy costs and anything else required in order to use that attack, such as discarding Energy cards. (No matter what type that Pokémon is, Alakazam's type is still Psychic.) This power can't be used if Alakazam is affected by a Special Condition.
Attacks
- Syncroblast80Cost: 3
If Alakazam and the Defending Pokémon don't have the same number of Energy cards attached to them, this attack's base damage is 20 instead of 80.
Weaknesses
- 超
Psychic ×2
eBay market prices
Sold and listed medians — tap a grade for comps
More conditions (eBay)
Add LP / MP / HP / DMG or a slab grade (PSA 8, ACE 9, BGS 9.5, …). Everyone sees the same prices; scheduled refreshes include these variants.
Listed on marketplace
Vendors currently listing this card/product on our marketplace. Click through to view or purchase (purchase flow coming soon).
No marketplace listings for this card right now.
More in this set
Other cards from Base Expansion Pack
Comments
Share your thoughts on this card — condition, value, pull rates, etc.
to comment.
No comments yet. Be the first to share your thoughts.